0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Glioblastoma multiforme (GBM) -Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-428
Home | Market Reports | Health | Health Conditions | Cancer
Glioblastoma multiforme Epidemiology Forecast to 2028

Glioblastoma multiforme (GBM) -Epidemiology Forecast to 2028

Code: DELV-Epid-428
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Glioblastoma multiforme (GBM) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Glioblastoma multiforme (GBM) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Glioblastoma multiforme (GBM) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Glioblastoma multiforme (GBM) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Glioblastoma multiforme (GBM) outlook. It also includes the explanation of changing trends of epidemiology outlining the Glioblastoma multiforme (GBM) scenario.

Glioblastoma multiforme (GBM) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Glioblastoma multiforme (GBM) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Glioblastoma multiforme (GBM) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Glioblastoma multiforme (GBM) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Glioblastoma multiforme (GBM)

Key assessments
• Patient Segmentation in Glioblastoma multiforme (GBM)
• Glioblastoma multiforme (GBM) Risk & Burden
• Factors driving growth in a specific Glioblastoma multiforme (GBM) patient population

1. Report Introduction
2. Glioblastoma multiforme (GBM) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Glioblastoma multiforme (GBM) in 2016
2.2. Patient Share Distribution of Glioblastoma multiforme (GBM) in 2028
3. Disease Background and Overview: Glioblastoma multiforme (GBM)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Glioblastoma multiforme (GBM) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Glioblastoma multiforme (GBM) in 7MM – By Countries
5. Epidemiology of Glioblastoma multiforme (GBM) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.1.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM) *
5.1.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.1.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.4.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM)*
5.4.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.4.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.5.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM)*
5.5.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.5.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.6.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM)*
5.6.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.6.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.7.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM)*
5.7.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.7.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.8.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM)*
5.8.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.8.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Glioblastoma multiforme (GBM)
5.9.3. Sub-Type Specific cases of the Glioblastoma multiforme (GBM)*
5.9.4. Sex- Specific Cases of the Glioblastoma multiforme (GBM)*
5.9.5. Diagnosed Cases of the Glioblastoma multiforme (GBM)
6. Unmet Needs of the Glioblastoma multiforme (GBM)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

 Table 1: Total Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in 7MM
Table 2: Total Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in France (2016-2028) *
Table 14: Diagnosed Cases of the Glioblastoma multiforme (GBM) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Glioblastoma multiforme (GBM) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028)


List of Figures

 Figure 1: Total Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Glioblastoma multiforme (GBM) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Glioblastoma multiforme (GBM) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Glioblastoma multiforme (GBM) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Glioblastoma multiforme (GBM) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and United States Blood Cancer Therapeutics Market Report Forecast 2022 2028
Global and United States Blood Cancer Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24U5687
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Ovarian Cancer Diagnostics Technologies Market Report Forecast 2022 2028
Global and United States Ovarian Cancer Diagnostics Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-23K5690
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Cancer Biotherapy Market Report Forecast 2022 2028
Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-18N5929
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Emerging Cancer Diagnostics Market Report Forecast 2022 2028
Global and United States Emerging Cancer Diagnostics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-12C6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart